Board Meeting
BXPHARMA Board to Review Q2 Results for FY 2021–22 on 27 January 2022
BXPHARMA will hold a board meeting on 27 January 2022 at 3:30 PM to review unaudited financial statements for Q2 of FY 2021–22.
BXPHARMAPharmaceuticals & Chemicals
Follow the latest news and corporate disclosures of Beximco Pharmaceuticals PLC. (DSE: BXPHARMA), including board meetings, quarterly financial results, dividend decisions, record dates, AGM notices and regulatory updates.
BXPHARMA will hold a board meeting on 27 January 2022 at 3:30 PM to review unaudited financial statements for Q2 of FY 2021–22.
BXPHARMA published a dividend disclosure.
কোম্পানি জানিয়েছে যে তারা সংশ্লিষ্ট শেয়ারহোল্ডারদের ৩০ জুন, ২০২১ তারিখে সমাপ্ত বছরের জন্য নগদ লভ্যাংশ বিতরণ করেছে।
BXPHARMA published a corporate disclosure on 19 December 2021. Read the full announcement for details.
ক্রেডিট রেটিং ইনফরমেশন অ্যান্ড সার্ভিসেস লিমিটেড (CRISL) কোম্পানিটিকে দীর্ঘমেয়াদে "AAA" এবং স্বল্পমেয়াদে "ST-1" হিসাবে রেট করেছে এবং এর 30 জুন, 2021 পর্যন্…
BXPHARMA published a corporate disclosure on 22 November 2021. Read the full announcement for details.
BXPHARMA published a corporate disclosure on 21 November 2021. Read the full announcement for details.
BXPHARMA published a corporate disclosure on 17 November 2021. Read the full announcement for details.
BXPHARMA published a corporate disclosure on 14 November 2021. Read the full announcement for details.
BXPHARMA published a corporate disclosure on 14 November 2021. Read the full announcement for details.
BXPHARMA published a corporate disclosure on 14 November 2021. Read the full announcement for details.
BXPHARMA will hold a board meeting on 11 November 2021 at 3:30 PM.